Wakefield Asset Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$3.82M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$3.68M |
| 3 |
Vanguard Total Bond Market
BND
|
+$3.49M |
| 4 |
Williams Companies
WMB
|
+$3.38M |
| 5 |
Duke Energy
DUK
|
+$3.35M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.85M |
| 2 |
Sysco
SYY
|
+$3.83M |
| 3 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$3.65M |
| 4 |
Moody's
MCO
|
+$3.34M |
| 5 |
Intel
INTC
|
+$3.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 8.34% |
| 2 | Financials | 8.21% |
| 3 | Industrials | 8.15% |
| 4 | Technology | 7.6% |
| 5 | Healthcare | 6.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Penumbra
PEN
$12.7B
| – | – |
-328
| Closed | -$49K |
|
227
PNC Financial Services
PNC
$100B
| – | – |
-9
| Closed | -$1K |
|
228
Ross Stores
ROST
$80.9B
| – | – |
-1,839
| Closed | -$182K |
|
|
FLNA
229
Filana Therapeutics
FLNA
$49.3M
| $0 | ﹤0.01% |
286
| – | – |
|
230
State Street
STT
$50.2B
| – | – |
-18
| Closed | -$2K |
|
231
Tapestry
TPR
$31.3B
| – | – |
-31
| Closed | -$2K |
|
232
Wynn Resorts
WYNN
$10.2B
| – | – |
-8
| Closed | -$1K |
|
|
PXD
233
DELISTED
Pioneer Natural Resource Co.
PXD
| – | – |
-9
| Closed | -$2K |
|
|
GRUB
234
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| – | – |
-622
| Closed | -$172K |
|
|
CXO
235
DELISTED
CONCHO RESOURCES INC.
CXO
| – | – |
-9
| Closed | -$1K |
|
Similar funds
Wakefield Asset Management's Q4 2018 Portfolio in Review
As of Q4 2018, Wakefield Asset Management held 235 positions worth $231M, down 9.5% from $256M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Wakefield Asset Management deployed $13.8M of net new capital in Q4 2018, opening 68 new positions and adding to 62 existing holdings. Its largest new stake was Bristol-Myers Squibb: 68,477 shares worth $3.56M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 8.3% of assets, down from 9.9% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $3.85M trimmed.
- Wakefield Asset Management's largest Q4 2018 buy was Bristol-Myers Squibb: 68,477 shares worth $3.56M.
- Wakefield Asset Management added most to Vanguard Mortgage-Backed Securities ETF in Q4 2018, an estimated $3.82M increase.
- Wakefield Asset Management's biggest Q4 2018 reduction was iShares Core S&P 500 ETF, cutting an estimated $3.85M.
- Wakefield Asset Management fully exited Idexx Laboratories in Q4 2018, selling an estimated $255K.
- Wakefield Asset Management's ten largest holdings make up 29% of its $231M portfolio in Q4 2018.
- Wakefield Asset Management opened 68 new positions and closed 23 in Q4 2018.
- Wakefield Asset Management's portfolio value fell 9.5% quarter-over-quarter to $231M.
Based on Wakefield Asset Management's 13F filing for Q4 2018, filed 15 Feb 2019.